Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma
Abstract Amplification of the MYCN proto-oncogene serves as a key marker of aggressive disease and poor treatment outcomes in certain pediatric tumors originating from the nervous system, including neuroblastoma and medulloblastoma. However, the complex nature of the challenging MYCN protein undersc...
Saved in:
| Main Authors: | Emma Lindell, Jing Guo, Miao Zhao, Natallia Rameika, Xi Lu, Tabea Wacker, Lei Zhong, Tobias Bergström, Sara Svanberg, Azazul I. Chowdhury, Peter Bergsten, Xingqi Chen, Daniel Bexell, Fredrik J. Swartling, Tobias Sjöblom, Xiaonan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07876-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer
by: Jianyuan Zeng, et al.
Published: (2024-12-01) -
A specific role for endothelial EPLIN-isoform-regulated actin dynamics in neutrophil transmigration
by: Mohammed Aldirawi, et al.
Published: (2025-05-01) -
Silver Nanoparticles Based on Annona muricata Peel Reduce Cell Viability in Medulloblastoma and Neuroblastoma Cell Lines
by: Eduardo Lira-Díaz, et al.
Published: (2024-01-01) -
Different Subcellular Localization of ALCAM Molecules in Neuroblastoma: Association with Relapse
by: Maria Valeria Corrias, et al.
Published: (2010-01-01) -
Chemotherapy For Medulloblastoma
by: J Gordon Millichap
Published: (1988-11-01)